Yoshiaki Ikuta

Identification of Glypican-3 as a Novel Tumor Marker for Melanoma

Tetsuya Nakatsura, Toshiro Kageshita, Shosuke Ito et al. · Clinical Cancer Research · 2004 · 175 citations · Full text

Medicine, Oncology, Pathology +13

Identification of HLA-A2- or HLA-A24-Restricted CTL Epitopes Possibly Useful for Glypican-3-Specific Immunotherapy of Hepatocellular Carcinoma

Hiroyuki Komori, Tetsuya Nakatsura, Satoru Senju et al. · Clinical Cancer Research · 2006 · 174 citations

Life Sciences, Immunology, Oncology +15

Identification of a Novel Tumor-Associated Antigen, Cadherin 3/P-Cadherin, as a Possible Target for Immunotherapy of Pancreatic, Gastric, and Colorectal Cancers

Katsunori Imai, Shinya Hirata, Atsushi Irie et al. · Clinical Cancer Research · 2008 · 110 citations · Full text

Life Sciences, Immunology, Oncology +17

HLA‐A2‐restricted CTL epitopes of a novel lung cancer‐associated cancer testis antigen, cell division cycle associated 1, can induce tumor‐reactive CTL

Michiko Harao, Shinya Hirata, Atsushi Irie et al. · International Journal of Cancer · 2008 · 92 citations

Life Sciences, Immunology, Oncology +17

Frailty predicts severe postoperative complications after elective colorectal surgery

Hirohisa Okabe, Takayuki Ohsaki, Katsuhiro Ogawa et al. · The American Journal of Surgery · 2018 · 87 citations

Medicine, Perioperative Medicine, Surgery +14